Ask a clinician which disease belongs to the neglected tropical diseases (NTDs) category and you will likely get a single answer — malaria, perhaps, or schistosomiasis. In fact, the World Health Organization’s official roster runs to 20 distinct diseases and disease groups, spanning bacterial infections, parasitic worms, viral diseases, fungal conditions, and even a traumatic injury. Understanding why these particular 20 sit together on one list, rather than what any single disease does to the body, is what actually explains the category.
Why "Neglected"? The Criteria Behind the List
WHO does not group these diseases by pathogen type or organ system. The unifying criteria are epidemiological and political rather than clinical. Diseases qualify as neglected tropical diseases because they are concentrated in tropical and subtropical regions, disproportionately affect communities without reliable access to sanitation, basic infrastructure, or health services, and have historically received far less research funding and public attention than diseases such as HIV/AIDS, tuberculosis, and malaria — the "big three" that dominate global health financing. Many also share structural features that make them hard to fight: vector-borne transmission, animal reservoirs that allow re-infection even after human cases are treated, and complex, multi-stage life cycles that a single drug or vaccine rarely interrupts entirely.
That combination — geographic concentration, political neglect, and biological complexity — is the actual admission criteria. It is why snakebite envenoming, a traumatic injury rather than an infection, sits on the same list as a parasitic worm disease like schistosomiasis: both disproportionately strike rural, under-resourced populations and have historically attracted a fraction of the research investment their disease burden would justify.
The 20 Diseases on WHO’s List
The current roster groups naturally by transmission route and clinical presentation. A working reference:
| Disease | Type |
|---|---|
| Buruli ulcer | Bacterial skin infection |
| Chagas disease | Parasitic (vector-borne) |
| Chikungunya | Viral (vector-borne) |
| Chromoblastomycosis and other deep mycoses | Fungal |
| Dengue | Viral (vector-borne) |
| Dracunculiasis (Guinea-worm disease) | Parasitic (waterborne) |
| Echinococcosis | Parasitic (zoonotic) |
| Foodborne trematode infections | Parasitic |
| Human African trypanosomiasis (sleeping sickness) | Parasitic (vector-borne) |
| Leishmaniasis | Parasitic (vector-borne) |
| Leprosy | Bacterial |
| Lymphatic filariasis | Parasitic (vector-borne) |
| Mycetoma | Fungal/bacterial |
| Noma | Bacterial/gangrenous |
| Onchocerciasis (river blindness) | Parasitic (vector-borne) |
| Rabies | Viral (zoonotic) |
| Scabies and other ectoparasitoses | Parasitic (skin) |
| Schistosomiasis | Parasitic (waterborne) |
| Snakebite envenoming | Traumatic injury |
| Soil-transmitted helminthiases | Parasitic |
| Taeniasis/cysticercosis | Parasitic (foodborne) |
| Trachoma | Bacterial (eye) |
| Yaws | Bacterial |
Note that the list is commonly cited as "20" even though this reference table shows more rows — WHO groups several related conditions (such as chromoblastomycosis with other deep mycoses, and taeniasis with cysticercosis) under a single list entry, since they share a causative organism or intervention pathway.
Five Strategies, Not One Response
A list this heterogeneous cannot be managed by a single tool. WHO organizes its NTD response around five core strategic interventions, each matched to a different disease profile:
- Preventive chemotherapy — large-scale, regular administration of safe, quality-assured medicines to entire population groups, typically in single annual or biannual doses, used for diseases like lymphatic filariasis, onchocerciasis, schistosomiasis, and soil-transmitted helminthiases.
- Innovative and intensified disease management — individual-level clinical care for diseases that are harder to manage at scale or that still lack simple diagnostic tools and treatments, such as human African trypanosomiasis and Chagas disease.
- Vector control — targeting the insects and other organisms that transmit the pathogen, central to controlling dengue, chikungunya, and leishmaniasis.
- Veterinary public health — applying veterinary science to interrupt zoonotic transmission, relevant wherever an animal reservoir sustains human infection, as with echinococcosis and rabies.
- Safe water, sanitation, and hygiene (WASH) — infrastructure-level prevention that cuts across nearly the whole list, since contaminated water and poor sanitation are upstream drivers of transmission for trachoma, schistosomiasis, soil-transmitted helminthiases, and Guinea-worm disease alike.
Most NTD-endemic settings run several of these strategies in parallel rather than choosing one. A district conducting a mass drug administration campaign for lymphatic filariasis, for instance, is simultaneously reliant on functioning cold storage, accurate dosing, and downstream water and sanitation investment to keep transmission from resuming once the campaign ends.
Why the List Matters Beyond Epidemiology
For readers tracking global health policy rather than clinical case management, the list itself functions as a resource-allocation signal. Inclusion on WHO’s NTD roster has historically preceded pooled procurement mechanisms, donated-drug programs, and coordinated elimination targets that a disease outside the list rarely attracts, regardless of its actual burden. That is part of why the boundary of the list — which 20 entries make the cut, and which related conditions do not — is itself a subject of ongoing debate among the field’s editorial and policy community, not a settled taxonomy.
The practical implication for programs operating in NTD-endemic regions is that the appropriate response depends entirely on which of the five strategies above a given disease falls under — a preventive chemotherapy campaign has almost nothing in common, logistically, with a vector-control program or a WASH infrastructure build, even though both diseases they target sit on the same 20-item list.
Conclusion
The neglected tropical diseases list is less a clinical category than an administrative one — a deliberately broad grouping meant to correct decades of underinvestment in diseases that share geography and neglect more than biology. Reading it as WHO intends, as 20 entries mapped onto five distinct intervention strategies, is a better starting point for understanding any single disease on it than treating the list as a single undifferentiated threat.